Chandrabose Karthikeyan Data-verified

OverviewAI-generated summary

Chandrabose Karthikeyan's research focuses on developing and evaluating novel drug delivery systems, particularly utilizing nanomaterials for targeted cancer therapy. His work includes the functionalization of multi-walled carbon nanotubes and graphene quantum dots with specific ligands to enhance drug delivery efficiency and reduce toxicity. Recent studies have investigated lysinated multiwalled carbon nanotubes conjugated with carbohydrate ligands for targeted doxorubicin delivery to breast cancer cells, and multifunctional graphene quantum dots for receptor targeting, drug delivery, and bioimaging in pancreatic cancer.

Karthikeyan also explores strategies to mitigate the inherent toxicity of nanomaterials, such as using curcumin coating for carbon nanotubes. His research extends to computational approaches, including quantitative structure-activity relationships, for drug design and prediction. He has also contributed to studies on the potential therapeutic applications of existing drugs, such as chloroquine/hydroxychloroquine in the context of COVID-19, and explored the use of deep learning for predicting disease stages, as seen in his work on diabetic retinopathy.

With a career publication count of 163 and an h-index of 27, Karthikeyan's scholarship demonstrates extensive contributions to the fields of nanomedicine, drug delivery, and computational drug design. His work is supported by collaborative efforts, as indicated by shared publications with researchers within his institution.

Metrics

• h-index: 27
• Publications: 147
• Citations: 2,387